Clinical Trial Update: 68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 trial investigates the 68Ga-FAPI-RGD PET/CT imaging tracer in lung cancer patients. The study is currently RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• 68Ga-FAPI-RGD

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Lung Neoplasms | EARLY_Phase 1 | Status: RECRUITING